Financhill
Sell
19

SYRE Quote, Financials, Valuation and Earnings

Last price:
$22.45
Seasonality move :
13.64%
Day range:
$21.60 - $23.76
52-week range:
$20.07 - $47.97
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
771.72x
P/B ratio:
7.69x
Volume:
686.8K
Avg. volume:
505.6K
1-year change:
1.49%
Market cap:
$1.3B
Revenue:
$886K
EPS (TTM):
-$4.12

Earnings Data

Next earnings date for SYRE
Feb 28
2025
Most recent earnings per share
-$1.06
Missed by $0.20
(Nov 7/2024)
Consensus Estimate
-$0.86
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SYRE Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $4M -- -- -$0.83 --
02/28/2025 Q4 $2.3M -- -- -$0.98 --
11/07/2024 Q3 -- -- -$1.06 -$0.86 -$0.20
08/07/2024 Q2 $2.9M -- -$0.59 -$0.91 $0.32
05/09/2024 Q1 -- -- -$0.72 -$1.08 $0.36
02/29/2024 Q4 $220K -- -$1.75 -$0.83 -$0.92
11/09/2023 Q3 -- -- -$0.86 -$0.85 -$0.02
06/30/2023 Q2 -- -- -$40.14 -$3.50 -$36.64
03/31/2023 Q1 -- -- -$4.89 -$4.38 -$0.52
12/31/2022 Q4 -- -- -$4.69 -$5.06 $0.37
09/30/2022 Q3 -- -- -$4.84 -- --
06/30/2022 Q2 -- -- -$6.75 -- --
03/31/2022 Q1 -- -- -$9.25 -- --
12/31/2021 Q4 -- -- -$7.77 -- --
09/30/2021 Q3 -- -- -$7.75 -- --
06/30/2021 Q2 -- -- -$2.50 -- --
03/31/2021 Q1 -- -- -$7.00 -- --
12/31/2020 Q4 -- -- -$8.50 -- --
09/30/2020 Q3 -- -- -$7.25 -- --
06/30/2020 Q2 -- -- -$10.00 -- --
03/31/2020 Q1 -- -- -$14.25 -- --
12/31/2019 Q4 -- -- -$16.25 -- --
09/30/2019 Q3 -- -- -$16.50 -- --
06/30/2019 Q2 -- -- -$13.75 -- --
03/31/2019 Q1 -- -- -$14.75 -- --
12/31/2018 Q4 -- -- -$16.00 -- --
09/30/2018 Q3 -- -- -$13.50 -- --
06/30/2018 Q2 -- -- -$11.50 -- --
03/31/2018 Q1 -- -- -$12.25 -- --
12/31/2017 Q4 -- -- -$9.50 -- --
09/30/2017 Q3 -- -- -$12.00 -- --
06/30/2017 Q2 -- -- -$11.75 -- --
03/31/2017 Q1 -- -- -$11.75 -- --
12/31/2016 Q4 -- -- -$8.25 -- --
09/30/2016 Q3 -- -- -$11.75 -- --
06/30/2016 Q2 -- -- -$11.50 -- --
03/31/2016 Q1 -- -- -$9.95 -- --
12/31/2015 Q4 -- -- -$8.72 -- --
09/30/2015 Q3 -- -- -$12.51 -- --
06/30/2015 Q2 -- -- -$5.23 -- --
03/31/2015 Q1 -- -- -$9.88 -- --

Spyre Therapeutics Earnings Questions

  • How Much did Spyre Therapeutics Generate in Revenue Last Quarter?

    Spyre Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Spyre Therapeutics Beat Earnings Last Quarter?

    Spyre Therapeutics announced earnings per share of -$1.06 which represents a miss of analyst forecast a -$0.86 per share.

  • Is Spyre Therapeutics Profitable?

    Spyre Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Spyre Therapeutics EPS Next Year?

    Spyre Therapeutics's earnings are forecast to decrease from -$13.76 per share to -$4.35 per share next year representing a decrease of -68.4%.

  • When is Spyre Therapeutics's Earnings Date?

    Spyre Therapeutics's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Uber Stock Recover?
Will Uber Stock Recover?

Shares of Uber Technologies (NYSE:UBER) have had a rough few…

Is ARK Next Generation Internet ETF a Good Investment?
Is ARK Next Generation Internet ETF a Good Investment?

The ARK Next Generation Internet ETF looks like a pretty…

Why Is Marvell Stock Up?
Why Is Marvell Stock Up?

Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 114x

Sell
39
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
87
CEG alert for Jan 11

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
1
MCY alert for Jan 11

Mercury General [MCY] is down 19.87% over the past day.

Buy
84
ATZAF alert for Jan 11

Aritzia [ATZAF] is up 17.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock